Joshua Allen
Technik-/Wissenschafts-/F&E-Leiter bei CHIMERIX, INC.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Lee T. Schalop | M | - |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | 15 Jahre |
Michael Sherman | M | 58 | 5 Jahre | |
Michael Andriole | M | 51 | 5 Jahre | |
Martha Demski | F | 71 | 19 Jahre | |
Michelle LaSpaluto | F | 50 | 13 Jahre | |
Martin Stogniew | M | 69 |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | 12 Jahre |
Roy W. Ware | M | - | 17 Jahre | |
David Jakeman | M | 47 | 15 Jahre | |
Victoria Vakiener | F | 60 | 3 Jahre | |
Lisa Decker | M | 55 | 1 Jahre | |
Robert Meyer | M | 65 | 6 Jahre | |
Clarence Machado | M | 60 | 10 Jahre | |
Pratik Multani | M | 57 | 4 Jahre | |
Michael Alrutz | M | 54 | 12 Jahre | |
Fred Middleton | M | 74 | 6 Jahre | |
Odin Naderer | M | - | 10 Jahre | |
Thomas Riga | M | 48 | 1 Jahre | |
Allen Melemed | M | 60 | 4 Jahre | |
Caryn Barnett | F | - | 4 Jahre | |
Christopher L. Jordan | M | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Wolfgang Oster | M | - |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | - |
Edward F. Greissing | M | 73 | 3 Jahre | |
Catherine Lynch Gilliss | M | 75 | 9 Jahre | |
Wafik El-Deiry | M | - |
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | - |
Randall Lanier | M | - | 16 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 25 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Joshua Allen
- Persönliches Netzwerk